LEO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 2.268
AS - Asia 1.492
EU - Europa 909
SA - Sud America 313
AF - Africa 44
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.039
Nazione #
US - Stati Uniti d'America 2.163
SG - Singapore 682
IT - Italia 490
CN - Cina 311
BR - Brasile 236
VN - Vietnam 144
IN - India 124
HK - Hong Kong 77
DE - Germania 74
GB - Regno Unito 73
CA - Canada 71
SE - Svezia 59
FI - Finlandia 34
NL - Olanda 34
AR - Argentina 25
RU - Federazione Russa 24
MX - Messico 23
ZA - Sudafrica 21
ID - Indonesia 20
FR - Francia 18
IQ - Iraq 18
JP - Giappone 16
TR - Turchia 15
CO - Colombia 14
BD - Bangladesh 13
UA - Ucraina 13
PK - Pakistan 12
ES - Italia 11
PL - Polonia 11
AU - Australia 10
RO - Romania 10
IL - Israele 9
VE - Venezuela 9
CZ - Repubblica Ceca 8
EC - Ecuador 8
CH - Svizzera 7
CL - Cile 7
MA - Marocco 7
MT - Malta 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
PH - Filippine 6
AT - Austria 5
BG - Bulgaria 5
IR - Iran 5
JO - Giordania 5
PE - Perù 5
PY - Paraguay 5
BE - Belgio 4
KE - Kenya 4
GR - Grecia 3
HR - Croazia 3
LT - Lituania 3
NG - Nigeria 3
NO - Norvegia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AL - Albania 2
BO - Bolivia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
GA - Gabon 2
HN - Honduras 2
IE - Irlanda 2
JM - Giamaica 2
KG - Kirghizistan 2
KW - Kuwait 2
LK - Sri Lanka 2
MN - Mongolia 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AO - Angola 1
BS - Bahamas 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GD - Grenada 1
GT - Guatemala 1
KR - Corea 1
KZ - Kazakistan 1
LV - Lettonia 1
MY - Malesia 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 5.039
Città #
San Jose 401
Singapore 250
Chandler 218
Ashburn 193
Dallas 184
Santa Clara 117
Milan 92
Bengaluru 84
Hefei 84
Hong Kong 73
Beijing 66
Lawrence 57
Princeton 57
Catanzaro 56
Ho Chi Minh City 50
Munich 45
Chicago 44
London 42
Catania 40
Wilmington 36
Hanoi 29
Los Angeles 28
New York 28
Boardman 25
Ottawa 22
Redwood City 22
São Paulo 19
Turku 19
Des Moines 18
Rome 17
Helsinki 15
Orem 15
Montreal 14
Palermo 14
Amsterdam 12
Brooklyn 12
Johannesburg 12
Tokyo 12
Boston 11
Atlanta 10
Toronto 10
Council Bluffs 9
Mexico City 9
Messina 8
Rio de Janeiro 8
San Nicola Manfredi 8
Shanghai 8
Warsaw 8
Brasília 7
Charlotte 7
Haiphong 7
San Francisco 7
Stockholm 7
The Dalles 7
Cosenza 6
Da Nang 6
Hải Dương 6
Istanbul 6
Olomouc 6
Tashkent 6
West Jordan 6
Biên Hòa 5
Bologna 5
Casalnuovo di Napoli 5
Chennai 5
Curinga 5
Falls Church 5
Florence 5
Guangzhou 5
Montague 5
Naples 5
Norwalk 5
Nuremberg 5
Padova 5
Seattle 5
Tel Aviv 5
Vancouver 5
Ankara 4
Ann Arbor 4
Assago 4
Augusta 4
Aversa 4
Bogotá 4
Curitiba 4
Lima 4
Madrid 4
Nairobi 4
Pune 4
Queens 4
Redmond 4
Rende 4
Salvador 4
Santiago 4
Sydney 4
Viagrande 4
Adams Center 3
Amman 3
Athens 3
Baghdad 3
Bari 3
Totale 2.862
Nome #
Genetics of reflex seizures and epilepsies in humans and animals 160
First evidence of an altered microbiota and intestinal damage and its link to absence epilepsy in a genetic animal model, the WAG/Rij rat 134
Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy 115
Effects of chronic sodium alendronate on depression and anxiety in a menopausal experimental model 101
Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats 91
Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability 90
Audiogenic epileptic DBA/2 mice strain as a model of genetic reflex seizures and SUDEP 86
N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG/Rij rat model of absence epilepsy 86
Huperizine A Receptors Cortico-Hippocampal Functional Connectivity after Bilateral AMPA Lesion of the Nucleus Basalis of Meinert 85
Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis 85
Increased efficacy of combining prebiotic and postbiotic in mouse models relevant to autism and depression 84
L’ipericina modifica l’attività theta cerebrale e produce effetti antidepressivo-simili: studio mediante qEEG in un modello sperimentale di depressione 80
Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus: Data from an in vivo model 79
Anthelminthic medicinal plants in veterinary ethnopharmacology: A network meta-analysis following the PRISMA-P and PROSPERO recommendations. 78
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy 77
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 74
Antiepileptogenic effects of Ethosuximide and Levetiracetam in WAG/Rij rats are only temporary 73
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects 71
Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin 70
Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG/Rij Rats 70
Cenobamate enhances the anticonvulsant effect of other antiseizure medications in the DBA/2 mouse model of reflex epilepsy 69
Vasostatin-1 restores autistic disorders in an idiopathic autism model (BTBR T+ Itpr3tf/J mice) by decreasing hippocampal neuroinflammation 68
Non-competitive AMPA glutamate receptors antagonism by perampanel as a strategy to counteract hippocampal hyper-excitability and cognitive deficits in cerebral amyloidosis 68
The potential role of cannabinoids in epilepsy treatment. 68
Cognitive impairment in the WAG/Rij rat absence model is secondary to absence seizures and depressive-like behavior 67
Renal denervation for resistant hypertension 66
Huperizine A reduces neuronal loss and enhances brain expression of nerve growth factor and high-affinity receptor TrkA, and reverses memory and cognitive deficits, in rats with excitotoxic lesion of nucleus basalis magnocellularis 66
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat 66
Everolimus improves memory and learning while worsening depressive- and anxiety-like behavior in an animal model of depression 65
Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation  64
Critical appraisal of cenobamate as adjunctive treatment of focal seizures in adults 64
Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta-analysis of risk factors 62
Long-Term High-Fat Diet Aggravates Absence Seizures and Neurobehavioral Disorders Without Inducing Metabolic Disorders in WAG/Rij Rats: Involvement of Systemic and Central Inflammation 61
Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy 60
The antiepileptic drug levetiracetam suppresses non-convulsive seizure activity and reduces ischemic brain damage in rats subjected to permanent middle cerebral artery occlusion 60
The Anticonvulsant Activity of a Flavonoid-Rich Extract from Orange Juice Involves both NMDA and GABA-Benzodiazepine Receptor Complexes 59
mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis 58
Antiepileptogenic effects of the selective COX-2 inhibitor etoricoxib, on the development of spontaneous absence seizures in WAG/Rij rats 58
Antidepressants drugs for seizures and epilepsy: Where do we stand? 57
Nano‐hydrogel embedded with quercetin and oleic acid as a new formulation in the treatment of diabetic foot ulcer: A pilot study 57
Colchicine in Managing Skin Conditions: A Systematic Review 57
An In Vivo Electroencephalographic Analysis of the Effect of Riluzole against Limbic and Absence Seizure and Comparison with Glutamate Antagonists 56
Real-World Safety Profile of Biologics Used in Rheumatology: A Six-Year Observational Pharmacovigilance Study in the Calabria Region 54
HDL (High-Density Lipoprotein) and ApoA-1 Potentially Modulate Pancreatic α-Cell Glucagon Secretion 54
Glucagon induces the hepatic expression of inflammatory markers in vitro and in vivo 54
Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence 53
Seizure susceptibility to various convulsant stimuli in the BTBR mouse model of autism spectrum disorders 53
Prescribing Pattern and Safety Profile of Biological Agents for Psoriasis in Real-World Practice: A Four-Year Calabrian Pharmacovigilance Analysis 53
Valproic Acid Metabolism and its Consequences on Sexual Functions 53
Comparative Analysis of the Treatment of Chronic Antipsychotic Drugs on Epileptic Susceptibility in Genetically Epilepsy-prone Rats 53
Cannabidiol and epilepsy: Rationale and therapeutic potential 52
Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl-2'-chloroethylamide and WIN 55,212-2 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 51
Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis 50
Are big potassium-type Ca2+-activated potassium channels a viable target for the treatment of epilepsy? 50
Lamotrigine positively affects the development of psychiatric comorbidity in epileptic animals, while psychiatric comorbidity aggravates seizures 50
Liraglutide chronic treatment prevents development of tolerance to antiseizure effects of diazepam in genetically epilepsy prone rats 49
Biofilm-dependent airway infections: A role for ambroxol? 49
Ranolazine Attenuates Brain Inflammation in a Rat Model of Type 2 Diabetes 48
Impact of micronutrients and nutraceuticals on cognitive function and performance in Alzheimer's disease 48
Perampanel effects in the WAG/Rij rat model of epileptogenesis, absence epilepsy, and comorbid depressive-like behavior 48
Diagnostic Biomarkers of Epilepsy 47
Quercetin-3-Oleate Contributes to Skin Wound Healing Targeting FFA1/GPR40 46
The Effects of Andrographis paniculata (Burm.F.) Wall. Ex Nees and Andrographolide on Neuroinflammation in the Treatment of Neurodegenerative Diseases 45
Long-term betamethasone 21-phosphate disodium treatment has distinct effects in CD1 and DBA/2 mice on animal behavior accompanied by opposite effects on neurogenesis 45
Upholding WAG/Rij rats as a model of absence epileptogenesis: Hidden mechanisms and a new theory on seizure development. 44
The sphingosine 1-phosphate signaling pathway in epilepsy: A possible role for the immunomodulator drug fingolimod in epilepsy treatment 44
The role of AMPA receptors and their antagonists in status epilepticus 44
Sex Differences in Hepatic Inflammation, Lipid Metabolism, and Mitochondrial Function Following Early Lipopolysaccharide Exposure in Epileptic WAG/Rij Rats 43
Two Olea europaea L. Extracts Reduce Harmful Effects in a Model of Neurotoxicity: Involvement of the Endoplasmic Reticulum 43
From Cannabis to Cannabidiol to Treat Epilepsy, Where Are We? 43
Modeling poststroke epilepsy and preclinical development of drugs for poststroke epilepsy 42
Epilepsy and Alzheimer's Disease: Current Concepts and Treatment Perspective on Two Closely Related Pathologies 42
The fast‐dissociating D2 antagonist antipsychotic JNJ‐37822681 is a neuronal Kv7 channel opener: Potential repurposing for epilepsy treatment 40
Circulating miRNAs as Novel Clinical Biomarkers in Temporal Lobe Epilepsy 40
mTOR signalling in epilepsy and epileptogenesis: preclinical and clinical studies 40
Intravenous carbamazepine for the treatment of epilepsy 40
mGlu3 metabotropic glutamate receptors as a target for the treatment of absence epilepsy: preclinical and human genetics data 39
GABAA Receptors Are Involved in the Seizure Blockage Prompted by a Polyphenol-Rich Extract of White Grape Juice in Rodents 38
Fingolimod Exerts only Temporary Antiepileptogenic Effects but Longer-Lasting Positive Effects on Behavior in the WAG/Rij Rat Absence Epilepsy Model 37
First-in-Class Dual Targeting Compounds for the Management of Seizures in Glucose Transporter Type 1 Deficiency Syndrome 33
Perampanel chronic treatment does not induce tolerance and decreases tolerance to clobazam in genetically epilepsy prone rats 31
Epilepsy and Related Neuropsychiatric Comorbidities: Basic and Clinical Research 26
Perampanel chronic treatment does not induce tolerance and decreases T tolerance to clobazam in genetically epilepsy prone rats 25
Histone Deacetylase Inhibitors Show Antiepileptogenic and Antidepressant Effects in the WAG/Rij Rat Model of Absence Epilepsy 25
Modulation of AMPA receptors as therapeutic strategy to counteract neuronal hyperexcitability and cognitive deficits in mouse models of cerebral amyloidosis 20
Cognitive Impairment in the WAG/Rij Rat Absence Model is Secondary to Absence Seizures and Depressive-Like Behavior 19
Real‑world safety and efficacy of biological agents in inflammatory bowel disease: a one-year post-marketing pharmacovigilance observational study in the Calabria region 19
N-PALMITOYLETHANOLAMINE ENHANCES ANTICONVULSANT EFFECTS OF SOME ANTIEPILEPTIC DRUGS AGAINST AUDIOGENIC SEIZURES IN DBA/2 MICE 18
Seizure susceptibility to various convulsant stimuli in BTBR mouse model of autism spectrum disorders 17
PROTECTIVE EFFECTS OF FINGOLIMOD ON EPILEPTOGENESIS AND NEUROPSYCHIATRIC COMORBIDITIES IN WAG/RIJ RATS, A GENETIC ANIMAL MODEL OF ABSENCE EPILEPSY AND DEPRESSIVE-LIKE BEHAVIOUR 15
SPONTANEOUSLY HYPERTENSIVE RATS WITH CEREBRAL SMALL VESSEL DISEASE ARE PRONE TO TEMPORAL LOBE EPILEPSY 14
Cognitive effects of Ranolazine in type 2 diabetes mellitus: Data from an in vivo model 12
Effects of high fat diet in the WAG/Rij rat model of epileptogenesis, absence epilepsy and neuropsychiatric comorbidities 12
Tocilizumab Prevents the Epileptogenesis and Psychiatric Comorbidity in WAG/Rij Rats, A Genetic Model of Absence Epilepsy, Epileptogenesis and Mild-Depression Comorbidity 12
Alpha-Lactalbumin Protects against Pentylenetetrazole-Induced Seizures in Mice Reducing Intestinal Inflammation 11
Totale 5.198
Categoria #
all - tutte 40.000
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.000


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 0 9 0
2021/2022217 1 8 2 44 8 12 2 40 41 25 25 9
2022/2023642 119 72 30 54 63 47 10 47 89 37 50 24
2023/2024395 65 49 30 38 23 54 25 31 6 22 17 35
2024/20251.019 131 29 43 34 86 139 44 44 134 45 125 165
2025/20262.584 175 233 292 339 261 130 351 143 362 225 73 0
Totale 5.198